Search

everythinglearnresearchcommunity

for

Search:↓

Targeting mitophagy may help treat alopecia areata by reducing inflammasome activation.

A temporary capillary cell type helps skin repair after radiation by promoting blood vessel growth.

A woman with a rare hair loss condition developed skin cancer in the bald area.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Chemotherapy often causes skin, hair, and nail problems in cancer patients.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

A virus protein can activate a pathway that may lead to abnormal hair follicle development.

Disrupting Bcl-xL in mice reduces skin cancer risk.

Six key genes can predict bladder cancer outcomes and may serve as prognostic biomarkers.

Sorafenib may cause hair loss in a way similar to alopecia areata.

Most pediatric cancer patients in the study developed skin problems, often due to their cancer treatment.

Paclitaxel chemotherapy causes premature aging and damage to hair follicles, potentially leading to permanent hair loss.

Skin lesions in Carney complex are likely caused by a specific group of skin cells that promote pigment production due to a genetic mutation.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Cancer patients, especially with blood cancers, face severe COVID-19 risks due to weakened immunity.

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.

Erlotinib can cause hair loss as a side effect.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Bortezomib chemotherapy can cause temporary skin rashes.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Cooling with antioxidants helps protect hair during chemotherapy.

AP-1 controls tumor cell type by affecting key signaling pathways.

A toddler with a rare adrenal gland tumor causing male-like physical changes was successfully treated with surgery.

Vitamin D may help protect against nonmelanoma skin cancer.

Bcl-2 overexpression protects against UVB damage but worsens hair loss from chemotherapy.